Although Kymriah's approval represents a landmark for chimeric antigen receptor T-cell (CAR-T) therapy in B-cell malignancies, solid tumors remain a formidable challenge.
机构:
Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada
BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, CanadaSimon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada